首页|基于网络药理学、分子对接技术及细胞实验探究柚皮苷二氢查尔酮在动脉粥样硬化治疗中的分子机制

基于网络药理学、分子对接技术及细胞实验探究柚皮苷二氢查尔酮在动脉粥样硬化治疗中的分子机制

扫码查看
目的:利用网络药理学、分子对接技术及细胞实验探究柚皮苷二氢查尔酮在动脉粥样硬化(AS)治疗中的作用靶点和分子机制.方法:通过GeneCards、TTD、OMIM和Swiss Target Prediction等数据库获得AS和柚皮苷二氢查尔酮的潜在靶点,利用韦恩图确定二者的共同靶点,导入STRING在线平台形成蛋白互作(PPI)网络关系图,利用Cytoscape 3.8.2 软件生成核心交集靶点图,同时将核心靶点输入DAVID数据库进行GO和KEGG通路富集分析,利用AutoDock4.2.6 软件对药物及核心靶点进行分子对接验证.最后,选用人脐静脉内皮细胞,通过H2O2 诱导建立AS氧化应激细胞模型进行体外生物学验证.结果:经过检索获得2044个AS相关疾病靶点和100 个柚皮苷二氢查尔酮作用靶点.韦恩图筛选获得 38 个交集靶点.PPI网络分析得到 10个核心靶点,按MCC评分依次为EGFR、CASP3、ESR1、MTOR、FN1、MMP9、PARP1、PIK3CA、CTSD、CDK2.通过GO和KEGG通路分析显示这些靶点主要涉及炎症、PI3K/Akt信号通路和细胞程序性死亡的信号途径等.分子对接分析结果显示,柚皮苷二氢查尔酮和多个核心靶点具有良好的结合效能.细胞实验显示,与Control组相比,H2O2 组细胞内活性氧簇(ROS)和Cleaved caspase-3的表达水平升高(F=17.77、73.31,均P<0.001),核因子κB(NF-κB)p65、基质金属蛋白酶 9(MMP-9)和肿瘤坏死因子-α(TNF-α)蛋白的表达上调明显(F=22.65、18.64、9.97,均P<0.05).与H2O2 组相比,高浓度的柚皮苷二氢查尔酮能抑制细胞内的ROS(P<0.01)及剪切胱天蛋白酶 3(Cleaved caspase-3)的表达升高(P<0.001),抑制NF-κB p65 激活(P<0.01)以及下调MMP-9 和TNF-α蛋白的表达(均P<0.01).结论:柚皮苷二氢查尔酮可通过多靶点、多途径发挥治疗AS的作用.
Exploring the molecular mechanism of naringin dihydrochalcone intervention in atherosclerosis based on network pharmacology,molecular docking and cell experiments
Objective:To explore the target and molecular mechanism of naringin dihydrochalcone in the treatment of atherosclerosis using network pharmacology,molecular docking techniques and cell experiments.Methods:The potential targets of AS and naringin di-hydrochalcone were obtained through databases such as GeneCards,TTD,OMIM,and Swiss Target Prediction.A Venn diagram was uti-lized to identify the common targets of the two compounds.Subsequently,these targets were imported into the STRING online platform to construct a protein-protein interaction(PPI)network diagram.The core intersecting target map was generated using Cytoscape 3.8.2 software.Additionally,the core targets were inputted into the DAVID database for Gene Ontology(GO)and KEGG pathway enrichment analysis.Molecular docking validation of the drug and core targets was performed using AutoDock 4.2.6 software.Finally,human umbili-cal vein endothelial cells were selected to establish an oxidative stress cell model induced by H2O2 for in vitro biological validation of AS.Results:Through retrieval,2 044 disease targets related to AS and 100 action targets of naringin dihydrochalcone were obtained.The Venn diagram screening yielded 38 intersection targets.The PPI network analysis identified 10 core targets,ranked by MCC score as follows:EGFR,CASP3,ESR1,MTOR,FN1,MMP9,PARP1,PIK3CA,CTSD,and CDK2.The analyses of GO and KEGG pathways indicated that these targets were mainly involved in inflammation,the PI3K/Akt signaling pathway,and the signaling pathways of pro-grammed cell death,etc.The results of molecular docking analysis demonstrated that naringin dihydrochalcone had favorable binding efficacy with multiple core targets.Cell experiments revealed that compared with the Control group,the expression levels of reactive oxy-gen species(ROS)and Cleaved caspase-3 in the H2O2 group increased(F=17.77,73.31,both P<0.001),and the expressions of NF-κB p65,MMP-9,and TNF-α proteins were significantly upregulated(F=22.65,18.64,9.97,all P<0.05).Compared with the H2O2 group,high concentrations of naringin dihydrochalcone could inhibit the intracellular ROS(P<0.01)and the increased expression of Cleaved caspase-3(P<0.001),inhibit the activation of NF-κB p65(P<0.01),and downregulate the expressions of MMP-9 and TNF-α proteins(P<0.01).Conclusion:Naringin dihydrochalcone can play a role in the treatment of AS through multiple targets and multiple pathways.

naringin dihydrochalconeatherosclerosisnetwork pharmacologymolecular dockingcell experiments

范丽文、张宇凡、李娇、魏丽萍

展开 >

天津医科大学研究生院,天津 300070

天津市人民医院心血管内科,天津 300121

柚皮苷二氢查尔酮 动脉粥样硬化 网络药理学 分子对接 细胞实验

2025

天津医科大学学报
天津医科大学

天津医科大学学报

影响因子:0.881
ISSN:1006-8147
年,卷(期):2025.31(1)